Randomized Phase II Trial Evaluating the Addition of

Randomized Phase II Study Evaluating the Addition of ... - PubMed

The checkpoint immunotherapeutic pembrolizumab induces responses in a small minority of patients with metastatic castration-resistant ...

Randomized phase II study evaluating the addition of ...

This study revealed that R233 + pem did not result in unexpected AEs, but did not lead to prolonged rPFS or OS compared to R223 alone.

A randomized phase II trial evaluating the addition of low dose, short ...

Conclusions: The addition of sunitinib to docetaxel was well-tolerated but did not improve outcomes. The possible negative impact in metastatic ...

Randomized Phase II Study Evaluating the Addition of ...

This first-in-human, randomized trial demonstrates that combining radium-223 with pembrolizumab does not significantly impact the tumor microenvironment.

A Randomized Phase II Trial Evaluation of the Addition of the ...

This is a randomized Phase II trial evaluating the addition of the Pediatric Cancer Resource Equity (PediCARE) health equity intervention to usual ...

Randomized Phase II Trial Evaluating the Addition of IGF-1R ...

This randomized phase III trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing ...

A randomized phase II trial evaluating the addition of low dose, short ...

We previously reported that low-dose, short-course sunitinib prior to neoadjuvant doxorubicin-cyclophosphamide (AC) normalised tumour ...

Randomized Phase II Study Evaluating Palbociclib in Addition to ...

PALLET is a phase II randomized trial that evaluated the effects of combination palbociclib plus letrozole as neoadjuvant therapy.

A phase II randomized study evaluating the addition of iniparib to ...

This randomized phase II study investigated the addition of iniparib to gemcitabine–cisplatin in metastatic non-small-cell lung cancer (NSCLC) patients.

A multicentric randomized phase II clinical trial evaluating high-dose ...

NCT 00978471 is a randomised phase II study of 44 patients with relapsed osteosarcoma. •. Arm A: chemotherapy + thiotepa and autologous transplantation; Arm B: ...

Design of phase II oncology trials evaluating combinations of ...

Randomized comparative trials should generally include a between-arm futility analysis. However, in addition to a between-arm futility analysis, the design ...

A randomized phase II study evaluating the combination of ...

The addition of pertuzumab to carboplatin-based chemotherapy did not substantially prolong PFS in unselected patients with platinum-sensitive ovarian cancer.

A phase II randomized study evaluating the addition of iniparib to ...

This randomized phase II study investigated the addition of iniparib to gemcitabine–cisplatin in metastatic non-small-cell lung cancer (NSCLC) patients.

A Randomized Phase II Study of a Combination of Docetaxel and S ...

We conducted a randomized phase II study to evaluate the efficacy and safety ... In addition, three patients (two in arm A, one in arm B) experienced ...

Randomized Phase II Trial and Tumor Mutational Spectrum Analysis ...

In addition to recurrently mutated genes, overexpression of the receptor ... A091201 was a randomized phase II trial evaluating cabozantinib (arm 1) ...

Randomized Phase II Trial Evaluating the Addition of

Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479 NSC# 750008) to Multiagent Chemotherapy for Patients ...

A Bayesian pick-the-winner design in a randomized phase II clinical ...

Abstract. Purpose: Many phase II clinical trials evaluate unique experimental drugs/combinations through multi-arm design to expedite the ...

the randomized phase II NeoPembrOV clinical trial - Nature

There are currently no reported results from randomized trials evaluating PD-1 inhibitors in combination with chemotherapy in ovarian cancer.

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on ...

... randomized phase 2 platform trial examines the efficacy of adding ... Randomized phase 3 registrational trials evaluating pembrolizumab in ...

Results From a Randomized Phase 2 Trial: Addition of SBRT to ...

The objective of the ABC-07 study was to assess the effectiveness and safety of incorporating SBRT with gemcitabine and cisplatin (gem/cis) in cases of locally ...